ROBO1, together with multiple ICMs, including CTLA-4, PD-1, and programmed death-ligand 1 (PD-L1), have been considered potential target antigens for effective HCC radioimmunotherapy [91]. The gene discussed is CD274; the disease is hepatocellular carcinoma.